Publications by authors named "Nicole G Chau"

44Publications

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.

Cancer 2020 Sep 18;126(17):3972-3981. Epub 2020 Jun 18.

Department of Hematology/Oncology, Memorial Sloan Kettering Cancer Center, New York City, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.33036DOI Listing
September 2020

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma.

Oral Oncol 2020 07 11;106:104690. Epub 2020 Apr 11.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; BC Cancer, Vancouver Centre, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2020.104690DOI Listing
July 2020

Microcystic Adnexal Carcinoma of the Face Treated With Definitive Chemoradiation: A Case Report and Review of the Literature.

Adv Radiat Oncol 2020 Mar-Apr;5(2):301-310. Epub 2019 Dec 13.

Department of Radiation Oncology Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.adro.2019.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136639PMC
December 2019

Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.

Oral Oncol 2018 10 17;85:29-34. Epub 2018 Aug 17.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA 703-389-1895, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13688375183029
Publisher Site
http://dx.doi.org/10.1016/j.oraloncology.2018.08.005DOI Listing
October 2018

Zebrafish blastomere screen identifies retinoic acid suppression of in adenoid cystic carcinoma.

J Exp Med 2018 10 12;215(10):2673-2685. Epub 2018 Sep 12.

Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20180939DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170170PMC
October 2018

Psychosocial distress and the preferred method of delivery of mind-body interventions among patients with head-and-neck cancer.

Patient Relat Outcome Meas 2018 3;9:129-136. Epub 2018 Apr 3.

Phyllis F Cantor Center for Research in Nursing and Patient Care Services.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/PROM.S149978DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892963PMC
April 2018

Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.

Am J Surg Pathol 2017 Nov;41(11):1473-1482

*Department of Pathology, Massachusetts General Hospital ¶Department of Surgery, Massachusetts General Hospital ‡Department of Pathology, Brigham and Women's Hospital §Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School ∥Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA #Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN †Northern Institute for Cancer Research, University of Newcastle, Newcastle on Tyne, UK.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00000478-201711000-0000
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000945DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657508PMC
November 2017

Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.

BMC Cancer 2017 03 16;17(1):200. Epub 2017 Mar 16.

Department of Dermatology, Brigham and Women's Hospital, 221 Longwood Ave., Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3194-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356405PMC
March 2017

Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.

Mod Pathol 2017 05 13;30(5):650-659. Epub 2017 Jan 13.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2016.239DOI Listing
May 2017

Highlights in Head and Neck Cancer.

JAMA Oncol 2017 04;3(4):441-442

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.3648DOI Listing
April 2017

Antiangiogenic agents in head and neck squamous cell carcinoma: Tired of going solo.

Cancer 2016 12 20;122(23):3592-3595. Epub 2016 Sep 20.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30352DOI Listing
December 2016

Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes.

Cancer Immunol Res 2016 08 16;4(8):679-87. Epub 2016 Jun 16.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-16-0031DOI Listing
August 2016

Heads Up! Predictive Gene Signatures in Head and Neck Cancer May Be Coming Soon.

Clin Cancer Res 2016 08 29;22(15):3710-2. Epub 2016 Apr 29.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0582DOI Listing
August 2016

Sequential and Concurrent Chemoradiation: State of the Art.

Hematol Oncol Clin North Am 2015 Dec 21;29(6):1061-74. Epub 2015 Oct 21.

Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2015.07.005DOI Listing
December 2015

Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back.

Oncologist 2015 Jul 3;20(7):699-701. Epub 2015 Jun 3.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492235PMC
July 2015

Marital status and head and neck cancer outcomes.

Cancer 2015 Apr 18;121(8):1273-8. Epub 2014 Dec 18.

Harvard School of Dental Medicine, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29171DOI Listing
April 2015

Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.

Curr Treat Options Oncol 2014 Dec;15(4):595-610

Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-014-0309-1
Publisher Site
http://dx.doi.org/10.1007/s11864-014-0309-1DOI Listing
December 2014

Locally advanced head and neck cancer.

Am Soc Clin Oncol Educ Book 2013 :237-44

From the Vanderbilt-Ingram Cancer Center, Nashville, TN; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2013.33.237DOI Listing
April 2016

Vandetanib for the treatment of medullary thyroid cancer.

Clin Cancer Res 2013 Feb 11;19(3):524-9. Epub 2012 Dec 11.

Medical Oncology, Head and Neck Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2353DOI Listing
February 2013

Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?

BMC Cancer 2011 Oct 5;11:426. Epub 2011 Oct 5.

Division of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-11-426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199018PMC
October 2011

The multidisciplinary approach to thymoma: combining molecular and clinical approaches.

J Thorac Oncol 2010 Oct;5(10 Suppl 4):S313-7

Division of Medical Oncology and Hematology, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181f20d9aDOI Listing
October 2010

Bereavement practices of physicians in oncology and palliative care.

Arch Intern Med 2009 May;169(10):963-71

Princess Margaret Hospital, Department of Medical Oncology and Hematology, University of Toronto, Toronto, ON M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinternmed.2009.118DOI Listing
May 2009

Pylephlebitis and pyogenic liver abscesses: a complication of hemorrhoidal banding.

Can J Gastroenterol 2007 Sep;21(9):601-3

Department of Medicine, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657991PMC
http://dx.doi.org/10.1155/2007/106946DOI Listing
September 2007